Search Results - Shavikumar, Sudeep

  • Showing 1 - 1 results of 1
Refine Results
  1. 1
    A Phase II Clinical Trial of the Pan PI3K Inhibitor, Buparlisib, for the Treatment of Relapsed and Refractory Chronic Lymphocytic Leukemia: Canadian Cancer Trials Group IND.216

    A Phase II Clinical Trial of the Pan PI3K Inhibitor, Buparlisib, for the Treatment of Relapsed and Refractory Chronic Lymphocytic Leukemia: Canadian Cancer Trials Group IND.216 by Assouline, Sarit, Amrein, Lilian, Banerji, Versha, Caplan, Stephen, Owen, Carolyn Jane, Hasegawa, Wanda, Robinson, Sue, Shavikumar, Sudeep, Prica, Anca, Peters, Anthea, Hagerman, Linda, Rodriguez, Laura, Skamene, Tanya, Panasci, Lawrence, Chen, Bingshu E., Hay, Annette E

    Published in Blood
    Get full text
    Article
    Save to List
    Saved in:

Search Tools: